⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

Official Title: A Randomized, Double-blind and Imitation, Placebo Parallel Control, Multicentre Phase III Study of TQB2450 With or Without Anlotinib as Consolidation Treatment in Subjects With Locally Advanced/Unresectable (Stage III) Non-Small Cell Lung Cancer That Have Not Progressed After Prior Concurrent/Sequential Chemoradiotherapy

Study ID: NCT04325763

Study Description

Brief Summary: This study is a randomized, double-blind, double-dummy,placebo parallel controlled, multi-centre,phase III clinical trial to evaluate the efficacy and safety of TQB2450 with or without anlotinib compared with placebo as consolidation treatment in subjects with locally advanced/unresectable (Stage III) Non-Small Cell Lung Cancer that has not progressed after prior concurrent/sequential chemoradiotherapy.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Anhui Chest Hospital, Hefei, Anhui, China

Peking Union Medical College Hospital, Beijing, Beijing, China

Chongqing University Cancer Hospital, Chongqing, Chongqing, China

The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China

Fujian Cancer Hospital, Fuzhou, Fujian, China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

The First Affiliated Hospital Sun Yat-Sen University, Guangzhou, Guangdong, China

Yuebei People's Hospital, Shaoguan, Guangdong, China

Affiliated Hospital of Guangdong Medical University, Zhangjiang, Guangdong, China

The Fifth Affiliated Hospital Sun Yat-Sen University, Zhuhai, Guangdong, China

Guangxi Medical University Affiliated Tumor Hospital, Nanning, Guangxi, China

The Fourth Hospital of Hebei medical University, Shijiazhuang, Hebei, China

Anyang Cancer Hospital, Anyang, Henang, China

Henan Cancer Hospital, Zhengzhou, Henan, China

Hubei Cancer Hospital, Wuhan, Hubei, China

Hunan Cancer Hospital, Changsha, Hunan, China

Xiangya Hospital Central South University, Changsha, Hunan, China

The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Huaian First People's Hospital, Huai'an, Jiangsu, China

Jiangsu Cancer Hospital, Nanjing, Jiangsu, China

Jiangsu People's Hospital, Nanjing, Jiangsu, China

The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Qilu Hospital of Shandong University, Jinan, Shandong, China

Baoji Central Hospital, Baoji, Shanxi, China

Shanxi Cancer Hospital, Taiyuan, Shanxi, China

Xijing Hospital of Airforce Medical University, Xi'an, Shanxi, China

First Affiliated Hospital of Xi'anjiantong University, Xi'an, Shanxi, China

Tianjin Cancer Hospital, Tianjin, Tianjin, China

The first Hospital of Zhengjiang Province, Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Zhejiang Hospital, Hangzhou, Zhejiang, China

Zhejiang People's Hospital, Hangzhou, Zhejiang, China

Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China

Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang, China

Taizhou Central Hospital, Taizhou, Zhejiang, China

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: